Akoya Biosciences

AKYA · NASDAQ

Price unavailable right now.

No price history for this range.

Latest news

Press releaseJun 20, 6:18 PM ETPRNewswire
AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
Press releaseMay 23, 2:21 PM ETPRNewswire
Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal
Press releaseMay 23, 9:10 AM ETPRNewswire
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs
NewsMay 21, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsMay 21, 8:07 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseMay 12, 4:05 PM ETGlobe Newswire
Akoya Biosciences Reports First Quarter 2025 Financial Results
Press releaseMay 7, 3:46 PM ETBusiness Wire
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
Press releaseApr 30, 8:00 AM ETBusiness Wire
Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders
Press releaseApr 29, 7:00 AM ETBusiness Wire
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
Press releaseApr 23, 8:00 AM ETGlobe Newswire
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
Press releaseApr 22, 8:45 PM ETPRNewswire
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of GB, YOTA, PORT, AKYA to Act
Press releaseApr 22, 4:34 PM ETPRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, RDFN, AKYA on Behalf of Shareholders
Press releaseApr 18, 1:00 PM ETPRNewswire
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - BRDG, AKYA, CKPT, QTRX
Press releaseApr 17, 8:30 AM ETBusiness Wire
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
Press releaseApr 14, 8:00 AM ETBusiness Wire
Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences
Press releaseApr 7, 8:15 AM ETBusiness Wire
Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya
Press releaseApr 5, 1:00 PM ETPRNewswire
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - OPTN, SLRN, AKYA, SHYF
Press releaseMar 24, 8:00 AM ETBusiness Wire
Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences
NewsMar 17, 4:09 PM ET
Kent Lake Urges Quanterix Management To Address Key Questions Regarding Its Proposed Transaction With Akoya Biosciences; Believes Proposed Transaction With Akoya Significantly Undervalues Quanterix; Encourages Shareholders To Vote Against Transaction To Protect Long-term Value Of Their Investment
Press releaseMar 17, 4:00 PM ETGlobe Newswire
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
Press releaseMar 17, 4:00 PM ETBusiness Wire
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call
Press releaseMar 11, 8:00 AM ETBusiness Wire
Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences
Press releaseMar 3, 8:00 AM ETBusiness Wire
Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board
Press releaseFeb 18, 3:40 PM ETBusiness Wire
Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences
Press releaseJan 28, 6:00 AM ETBusiness Wire
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner
Press releaseJan 13, 10:10 PM ETPRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SSTK, AKYA, POAI on Behalf of Shareholders
Press releaseJan 10, 5:35 PM ETBusiness Wire
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
Press releaseJan 10, 2:00 PM ETPRNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ESSA, AKYA, CCNE, QTRX on Behalf of Shareholders
Press releaseJan 10, 7:00 AM ETBusiness Wire
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
Press releaseDec 10, 8:15 AM ETGlobe Newswire
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
Press releaseDec 2, 10:18 AM ETPRNewswire
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend
NewsNov 15, 4:06 PM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsNov 14, 3:32 AM ET
Earnings Scheduled For November 14, 2024
NewsAug 6, 12:00 PM ET
A Closer Look at 4 Analyst Recommendations For Akoya Biosciences

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Akoya Biosciences Reports First Quarter 2025 Financial Results

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of GB, YOTA, PORT, AKYA to Act

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, RDFN, AKYA on Behalf of Shareholders

$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - BRDG, AKYA, CKPT, QTRX

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - OPTN, SLRN, AKYA, SHYF

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

Kent Lake Urges Quanterix Management To Address Key Questions Regarding Its Proposed Transaction With Akoya Biosciences; Believes Proposed Transaction With Akoya Significantly Undervalues Quanterix; Encourages Shareholders To Vote Against Transaction To Protect Long-term Value Of Their Investment

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SSTK, AKYA, POAI on Behalf of Shareholders

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ESSA, AKYA, CCNE, QTRX on Behalf of Shareholders

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

12 Health Care Stocks Moving In Friday's Pre-Market Session

Earnings Scheduled For November 14, 2024

A Closer Look at 4 Analyst Recommendations For Akoya Biosciences